--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q3249.000K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Citigroup
C
Bank of America
BAC
Apple
AAPL
American Express
AXP
Chevron
CVX
US Stock MarketDetailed Quotes
AVTX Avalo Therapeutics
- 7.3500
- -0.3800-4.92%
Close Feb 14 16:00 ET
- 7.7100
- +0.3600+4.90%
Post 20:01 ET
77.18MMarket Cap0.08P/E (TTM)
8.0000High7.2900Low49.08KVolume7.7700Open7.7300Pre Close364.22KTurnover2.06%Turnover RatioLossP/E (Static)10.50MShares34.460052wk High3.66P/B17.49MFloat Cap4.240052wk Low--Dividend TTM2.38MShs Float22031.7120Historical High--Div YieldTTM9.19%Amplitude3.9501Historical Low7.4200Avg Price1Lot Size
Avalo Therapeutics Key Stats
Avalo Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Avalo Therapeutics Earnings Reports
Read more
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Analysis
Price Target
No Data